Ready use rescue pen successfully treats hypoglycemia diabetes patients

Of an investigational ready-to-use rescue pencil for that treatment of acute hypoglycemia in patients with diabetes. The pencil is really a liquid-stable glucagon Auto Injector, developed with The entire findings of these trials won’t be published until after this calendar year, no matter how the business said that the trials have been a triumph, with all the statistics shared with all the FDA at a pre-New Drug Application meeting.

Results in the Human Factors Character and reliability study demonstrated That 99 percent of an individual could administer the Xeris rescue pencil. Full consequences of this Individual Factors trial will probably be presented in the Advanced Technologies and Treatments for Diabetes summit in Vienna. “Xeris is OnTrack to submit an NDA to the ready-to-use glucagon Rescue pencil to your treatment of acute hypoglycemia in late Q2 with the The Business has also Initiated a Stage 3b study. This trial will Concentrate on prep and Management period of current crisis fittings . the Xeris rescue pencil.


Our most popular topics on Managedcaremag.com